Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
PaperCitations, authors & open-access status
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 545 citations, 2012 year and green oa status.
545
Citations
2012
Year
green
OA Status